Japan Human Coagulation Factor VII Market Report 2016

August 2016 | 117 pages | ID: JC8BB8FE54BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Human Coagulation Factor VII

Revenue, means the sales value of Human Coagulation Factor VII

This report studies sales (consumption) of Human Coagulation Factor VII in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Baxter
• Bayer
• Pfizer
• CSL
• Grifols
• Octapharma
• BPL
• Kedrion

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Human Coagulation Factor VII in each application, can be divided into

• Hemophilia A
• Spontanous + Traum
• Surgical

Contents

Japan Human Coagulation Factor VII Market Report 2016

1 HUMAN COAGULATION FACTOR VII OVERVIEW

1.1 Product Overview and Scope of Human Coagulation Factor VII
1.2 Classification of Human Coagulation Factor VII
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Human Coagulation Factor VII
  1.3.1 Hemophilia A
  1.3.2 Spontanous + Traum
  1.3.3 Surgical
1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Human Coagulation Factor VII (2011-2021)
  1.4.1 Japan Human Coagulation Factor VII Sales and Growth Rate (2011-2021)
  1.4.2 Japan Human Coagulation Factor VII Revenue and Growth Rate (2011-2021)

2 JAPAN HUMAN COAGULATION FACTOR VII COMPETITION BY MANUFACTURERS

2.1 Japan Human Coagulation Factor VII Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 Japan Human Coagulation Factor VII Revenue and Share by Manufactures (2015 and 2016)
2.3 Japan Human Coagulation Factor VII Average Price by Manufactures (2015 and 2016)
2.4 Human Coagulation Factor VII Market Competitive Situation and Trends
  2.4.1 Human Coagulation Factor VII Market Concentration Rate
  2.4.2 Human Coagulation Factor VII Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 JAPAN HUMAN COAGULATION FACTOR VII SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 Japan Human Coagulation Factor VII Sales and Market Share by Type (2011-2016)
3.2 Japan Human Coagulation Factor VII Revenue and Market Share by Type (2011-2016)
3.3 Japan Human Coagulation Factor VII Price by Type (2011-2016)
3.4 Japan Human Coagulation Factor VII Sales Growth Rate by Type (2011-2016)

4 JAPAN HUMAN COAGULATION FACTOR VII SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 Japan Human Coagulation Factor VII Sales and Market Share by Application (2011-2016)
4.2 Japan Human Coagulation Factor VII Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 JAPAN HUMAN COAGULATION FACTOR VII MANUFACTURERS PROFILES/ANALYSIS

5.1 Baxter
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human Coagulation Factor VII Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Baxter Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer
  5.2.2 Human Coagulation Factor VII Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Pfizer
  5.3.2 Human Coagulation Factor VII Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Pfizer Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 CSL
  5.4.2 Human Coagulation Factor VII Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 CSL Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Grifols
  5.5.2 Human Coagulation Factor VII Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Grifols Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Octapharma
  5.6.2 Human Coagulation Factor VII Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Octapharma Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 BPL
  5.7.2 Human Coagulation Factor VII Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 BPL Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Kedrion
  5.8.2 Human Coagulation Factor VII Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Kedrion Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 HUMAN COAGULATION FACTOR VII MANUFACTURING COST ANALYSIS

6.1 Human Coagulation Factor VII Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Human Coagulation Factor VII

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Human Coagulation Factor VII Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Human Coagulation Factor VII Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 JAPAN HUMAN COAGULATION FACTOR VII MARKET FORECAST (2016-2021)

10.1 Japan Human Coagulation Factor VII Sales, Revenue Forecast (2016-2021)
10.2 Japan Human Coagulation Factor VII Sales Forecast by Type (2016-2021)
10.3 Japan Human Coagulation Factor VII Sales Forecast by Application (2016-2021)
10.4 Human Coagulation Factor VII Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Human Coagulation Factor VII
Table Classification of Human Coagulation Factor VII
Figure Japan Sales Market Share of Human Coagulation Factor VII by Type in 2015
Table Application of Human Coagulation Factor VII
Figure Japan Sales Market Share of Human Coagulation Factor VII by Application in 2015
Figure Hemophilia A Examples
Figure Spontanous + Traum Examples
Figure Surgical Examples
Figure Japan Human Coagulation Factor VII Sales and Growth Rate (2011-2021)
Figure Japan Human Coagulation Factor VII Revenue and Growth Rate (2011-2021)
Table Japan Human Coagulation Factor VII Sales of Key Manufacturers (2015 and 2016)
Table Japan Human Coagulation Factor VII Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Coagulation Factor VII Sales Share by Manufacturers
Figure 2016 Human Coagulation Factor VII Sales Share by Manufacturers
Table Japan Human Coagulation Factor VII Revenue by Manufacturers (2015 and 2016)
Table Japan Human Coagulation Factor VII Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Japan Human Coagulation Factor VII Revenue Share by Manufacturers
Table 2016 Japan Human Coagulation Factor VII Revenue Share by Manufacturers
Table Japan Market Human Coagulation Factor VII Average Price of Key Manufacturers (2015 and 2016)
Figure Japan Market Human Coagulation Factor VII Average Price of Key Manufacturers in 2015
Figure Human Coagulation Factor VII Market Share of Top 3 Manufacturers
Figure Human Coagulation Factor VII Market Share of Top 5 Manufacturers
Table Japan Human Coagulation Factor VII Sales by Type (2011-2016)
Table Japan Human Coagulation Factor VII Sales Share by Type (2011-2016)
Figure Japan Human Coagulation Factor VII Sales Market Share by Type in 2015
Table Japan Human Coagulation Factor VII Revenue and Market Share by Type (2011-2016)
Table Japan Human Coagulation Factor VII Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Coagulation Factor VII by Type (2011-2016)
Table Japan Human Coagulation Factor VII Price by Type (2011-2016)
Figure Japan Human Coagulation Factor VII Sales Growth Rate by Type (2011-2016)
Table Japan Human Coagulation Factor VII Sales by Application (2011-2016)
Table Japan Human Coagulation Factor VII Sales Market Share by Application (2011-2016)
Figure Japan Human Coagulation Factor VII Sales Market Share by Application in 2015
Table Japan Human Coagulation Factor VII Sales Growth Rate by Application (2011-2016)
Figure Japan Human Coagulation Factor VII Sales Growth Rate by Application (2011-2016)
Table Baxter Basic Information List
Table Baxter Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter Human Coagulation Factor VII Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Human Coagulation Factor VII Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Human Coagulation Factor VII Sales Market Share (2011-2016)
Table CSL Basic Information List
Table CSL Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Human Coagulation Factor VII Sales Market Share (2011-2016)
Table Grifols Basic Information List
Table Grifols Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols Human Coagulation Factor VII Sales Market Share (2011-2016)
Table Octapharma Basic Information List
Table Octapharma Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma Human Coagulation Factor VII Sales Market Share (2011-2016)
Table BPL Basic Information List
Table BPL Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
Table BPL Human Coagulation Factor VII Sales Market Share (2011-2016)
Table Kedrion Basic Information List
Table Kedrion Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kedrion Human Coagulation Factor VII Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Coagulation Factor VII
Figure Manufacturing Process Analysis of Human Coagulation Factor VII
Figure Human Coagulation Factor VII Industrial Chain Analysis
Table Raw Materials Sources of Human Coagulation Factor VII Major Manufacturers in 2015
Table Major Buyers of Human Coagulation Factor VII
Table Distributors/Traders List
Figure Japan Human Coagulation Factor VII Production and Growth Rate Forecast (2016-2021)
Figure Japan Human Coagulation Factor VII Revenue and Growth Rate Forecast (2016-2021)
Table Japan Human Coagulation Factor VII Production Forecast by Type (2016-2021)
Table Japan Human Coagulation Factor VII Consumption Forecast by Application (2016-2021)